1-4 of 4
myelosuppression
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Therapy for myeloproliferative neoplasms: when, which agent, and how?

Holly L. Geyer, Ruben A. Mesa
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 277–286.
https://doi.org/10.1182/asheducation-2014.1.277
Published: 2014
Journal Articles

JAK inhibition in the myeloproliferative neoplasms: lessons learned from the bench and bedside

Jason Gotlib
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 529–537.
https://doi.org/10.1182/asheducation-2013.1.529
Published: 2013
Journal Articles

Targeting B-cell receptor signaling: changing the paradigm

Nathan Fowler, Eric Davis
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 553–560.
https://doi.org/10.1182/asheducation-2013.1.553
Published: 2013
Journal Articles

Therapeutic potential of JAK2 inhibitors

Srdan Verstovsek
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 636–642.
https://doi.org/10.1182/asheducation-2009.1.636
Published: 2009